SCHEMBL19031884

SCHEMBL19031884

CC(C(N)=O)(c1ccccc1)c1cncnc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 1/20 0.52
KMT2A Q03164 1/20 0.52
HDAC3 O15379 1/20 0.44
HDAC4 P56524 1/20 0.44
HDAC1 Q13547 1/20 0.44
HDAC7 Q8WUI4 1/20 0.44
HDAC2 Q92769 1/20 0.44
HDAC10 Q969S8 1/20 0.44
HDAC11 Q96DB2 1/20 0.44
HDAC8 Q9BY41 1/20 0.44
HDAC6 Q9UBN7 1/20 0.44
HDAC9 Q9UKV0 1/20 0.44
HDAC5 Q9UQL6 1/20 0.44
CYP19A1 P11511 4/20 0.44
KDM4E B2RXH2 1/20 0.41
KCNN4 O15554 2/20 0.39
LMNA P02545 1/20 0.38
CYP1A2 P05177 1/20 0.38
CYP3A4 P08684 1/20 0.38
CYP11B1 P15538 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19031888 0.86 HDAC3 (0.47) MAPTKMT2AHDAC3HDAC4HDAC1
SCHEMBL2781433 0.85 MAPT (0.68) MAPTKMT2AHDAC3HDAC4HDAC1
SCHEMBL26133831 0.85 LMNA (0.51) MAPTKMT2AHDAC3HDAC4HDAC1
Hydrochloric Acid SCHEMBL29096654 0.83 MAPT (0.65) MAPTKMT2AHDAC3HDAC4HDAC1
SCHEMBL2202450 0.82 KMT2A (0.55) MAPTKMT2AHDAC3HDAC4HDAC1
SCHEMBL28677835 0.80 KCNN4 (0.51) KMT2AHDAC3HDAC4HDAC1HDAC7
SCHEMBL17591687 0.79 CYP3A4 (0.56) MAPTKMT2ACYP19A1LMNACYP1A2
SCHEMBL4800452 0.77 MAPT (0.57) MAPTKMT2AHDAC3HDAC4HDAC1
SCHEMBL19031897 0.75 HDAC3 (0.49) KMT2AHDAC3HDAC4HDAC1HDAC7
SCHEMBL28151671 0.75 KCNN4 (0.68) MAPTKMT2AHDAC3HDAC4HDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108738320-B cGMP modulators for the treatment of cardiovascular diseases 默沙东公司 2021-11-19 CN disclosed
EP-3394067-A1 4-AMINO-2-(1H-PYRAZOLO[3,4-B]PYRIDIN-3-YL)-6-OXO-6,7-DIHYDRO-5H-PYRROLO[2,3-D]PYRIMIDINE DERIVATIVES AND THE RESPECTIVE (1H-INDAZOL-3-YL) DERIVATIVES AS CGMP MODULATORS FOR TREATING CARDIOVASCULAR DISEASES Merck Sharp & Dohme Corp. (US) 2018-10-31 EP disclosed
WO-2017112617-A1 4-AMINO-2-(1H-PYRAZOLO[3,4-B]PYRIDIN-3-YL)-6-OXO-6,7-DIHYDRO-5H-PYRROLO[2,3-D]PYRIMIDINE DERIVATIVES AND THE RESPECTIVE (1H-INDAZOL-3-YL) DERIVATIVES AS CGMP MODULATORS FOR TREATING CARDIOVASCULAR DISEASES MERCK SHARP & DOHME CORP. (US) 2017-06-29 WO disclosed